# The Diagnostic Accuracy of Electrical Impedance Spectroscopy-Assisted Colposcopy, HPV mRNA Test, and P16/Ki67 Immunostaining as CIN2+ Predictors in Greek Population

**Authors:** Nikolaos Tsampazis, Eleftherios Vavoulidis, Chrysoula Margioula-Siarkou, Marianthi Symeonidou, Stergios Intzes, Alexios Papanikolaou, Konstantinos Dinas, Angelos Daniilidis

PMC · DOI: 10.3390/diagnostics14131379 · Diagnostics · 2024-06-28

## TL;DR

This study shows that adding electrical impedance spectroscopy to colposcopy improves cervical cancer detection accuracy in Greek women.

## Contribution

Demonstrates EIS-assisted colposcopy's superior diagnostic accuracy for CIN2+ detection compared to standard methods in a Greek population.

## Key findings

- EIS-assisted colposcopy achieved 100% sensitivity and 95.45% specificity for CIN2+ detection.
- EIS detected 44 additional CIN2+ cases missed by standalone colposcopy, a 45.83% increase.
- EIS-assisted colposcopy outperformed HPV mRNA testing and p16/Ki67 immunostaining in predictive values.

## Abstract

Objective: To evaluate the diagnostic accuracy of Electrical Impedance Spectroscopy (EIS)-assisted colposcopy in detecting CIN2+ Greek women towards standalone colposcopy, HPV mRNA testing, and p16/Ki67 immunostaining. Methods: We conducted a cross-sectional observational study at the Cervical Pathology Clinic of the 2nd Obstetrics-Gynecology University Department of Hippokration Hospital Thessaloniki involving 316 patients from January 2022 to August 2023. All participants provided liquid-based cervical samples for cytology, HPV mRNA testing, and p16/Ki67 immunostaining. Main Outcome Measures: Subsequently, participants underwent both standalone colposcopy and EIS/ZedScan-assisted colposcopy, followed by cervical punch biopsies. Results: The incorporation of EIS significantly enhanced the sensitivity of colposcopy, increasing it from 54.17% to 100%, equivalent to that of HPV mRNA testing and p16/Ki67 immunostaining, while achieving a high specificity (95.45%). The specificities observed with EIS/ZedScan-assisted and standalone colposcopy were notably superior to those of HPV-related biomarkers (HPV mRNA test and p16/Ki67 immunostaining). When compared to standalone colposcopy, HPV mRNA testing, and p16/Ki67 immunostaining, EIS/ZedScan-assisted colposcopy demonstrated the most favorable combination of Positive and Negative Predictive Values, at 90.57% and 100%, respectively. The inclusion of EIS/ZedScan in colposcopy led to the detection of 44 additional cases of true CIN2+ (100% of the total CIN2+ confirmed histologically) that were missed by standalone colposcopy. This discovery suggests a 45.83% increase in the detection of CIN2+ cases. Conclusions: The integration of EIS with colposcopy has demonstrated effectiveness in detecting cervical lesions, resulting in a significant detection increase of CIN2+ cases while offering optimal levels of sensitivity, specificity, and predictive values for CIN2+ detection.

## Linked entities

- **Proteins:** CDKN2A (cyclin dependent kinase inhibitor 2A), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}
- **Diseases:** cervical lesions (MESH:D002575)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11240963/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC11240963/full.md

---
Source: https://tomesphere.com/paper/PMC11240963